Stay updated with breaking news from Breakthrough Designation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Partnership will accelerate development of the industry's first predictive device for Alzheimer's Disease to be expanded to diagnosis of Parkinson's disease. Altoida, Inc. the world's leading Precision
LONDON and SALT LAKE CITY, Oct. 21, 2021 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX), (LSE: RENX) an artificial intelligence-enabled in vitro...
/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using...
/PRNewswire/ -- Biofourmis, a Boston-based global leader in digital therapeutics and virtual care that powers personalized predictive care, has been named the...
Investegate announcements from Renalytix PLC, Renalytix to Report Q4 and Full Year Results